Latest Muscle relaxants Stories

2008-09-10 15:00:37

KENILWORTH, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that the European launch of BRIDION(R) (sugammadex) injection has begun with its introduction this week in Sweden, and that the product is expected to be available soon in the United Kingdom and Germany, with several other European markets to follow by the end of the year and in early 2009. "The introduction of BRIDION in Europe represents an important advance for anesthesiologists and the...

2008-09-03 18:00:41

Using functional magnetic resonance imaging, Dutch researchers said cognitive deficits were reversed after six weeks of sleep therapy. The study, published in the journal Sleep, found that cognitive processes related to verbal fluency are compromised in people with insomnia despite the absence of a behavioral deficit. However, these specific brain function alterations can be reversed through non-pharmacological treatment with sleep therapy, the study said. The study authors suggest sleep...

2008-09-03 13:17:57

Analysts in the UK have reported a surge in popularity of the drug diazepam, better known as Valium, among drug users. According to independent drug research organization DrugScope, diazepam use as a heroin substitute is increasing among drug users in 15 out of 20 towns it surveyed. Known on the street as "Ëœblues' of "Ëœvallies', Valium is a class C drug, but experts are concerned about the rise in its use among class A drug users over the past 12 months. DrugScope...

2008-07-29 18:00:51

KENILWORTH, N.J., July 29 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that the European Commission (EC) has approved BRIDION(R) (sugammadex) injection, the first and only selective relaxant binding agent (SRBA) and the first major pharmaceutical advance in the field of anesthesia in two decades. BRIDION is indicated for routine reversal of the commonly used muscle relaxants rocuronium or vecuronium and for immediate reversal of rocuronium in adults, and for...

2008-07-26 18:00:17

A GP who gave sleeping pills to an elderly patient so she could commit suicide said yesterday he "regretted the circumstances" which resulted in his censure by the General Medical Council. Dr Iain Kerr, 61, was suspended from practising medicine for six months for prescribing sodiumamytal to a retired businesswoman after she told him she had considered suicide. John Donnelly, chairman of the GMC Fitness to Practise Panel, told the doctor he had allowed his views on physician-assisted...

2008-07-23 03:00:58

A GP who gave a potentially suicidal patient sleeping pills faces being struck off. Dr Iain Kerr, 61, prescribed 30 sodium amytal pills to a retired businesswoman in 1998 after she told him she had considered suicide. Yesterday, a General Medical Council fitness to practise panel told him that it was "inappropriate, irresponsible, liable to bring the profession into disrepute and not in your patient's best interest". The same ruling was made against the Glasgow GP for failing to refer...

2008-07-18 12:00:26

By HELEN PUTTICK HEALTH CORRESPONDENT A GP accused of prescribing sleeping tablets to enable a pensioner to end her life was criticised by a General Medical Council expert yesterday . Dr Leonard Peter told a GMC hearing that the standard of care provided by Dr Iain Kerr, from Glasgow, fell far below that expected of a general practitioner. Dr Peter was called to give evidence by the GMC's counsel on the third day of the hearing which is considering Dr Kerr's fitness to practise...

2008-07-13 21:00:08

Neurogen Corporation (Nasdaq: NRGN) today announced that, as planned, it commenced a Phase 2/3 clinical trial in chronic insomnia patients with the Company's insomnia agent, adipiplon and that, based upon reports from initial dosing of a higher than anticipated rate of unwanted next day effects, the Company has suspended dosing in the study. Neurogen believes that the bilayer tablet formulation of adipiplon being used in the study may not be performing as expected. The Company plans...

2008-03-11 18:00:45

KENILWORTH, N.J., March 11 /PRNewswire-FirstCall/ -- Schering-Plough today announced that the U.S. Food and Drug Administration (FDA) Advisory Committee on Anesthetics and Life Support has recommended sugammadex for approval. After reviewing data on the safety and efficacy of the medication, the committee unanimously recommended approval of the company's application for marketing. The FDA is not bound by the committee's recommendations; however, they usually are considered carefully...

2008-02-07 06:00:00

Napping is a necessity for Alissa Vladimir on many days, and it's not because she's a toddler. The 23-year-old public relations associate from Philadelphia has insomnia, a sleep disorder characterized by difficulty falling asleep, staying asleep or waking up too early. Sleepless until the wee hours most nights, Vladimir often rises weary. "I am cranky and more easily annoyed when I have a bad night. On bad days I just want to get everything over with so I can lie down," she says. To achieve...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'